SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-096639
Filing Date
2024-08-14
Accepted
2024-08-14 06:50:21
Documents
65
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q igms-20240630.htm   iXBRL 10-Q 2330131
2 EX-3.1 igms-ex3_1.htm EX-3.1 54765
3 EX-31.1 igms-ex31_1.htm EX-31.1 14731
4 EX-31.2 igms-ex31_2.htm EX-31.2 13630
5 EX-32.1 igms-ex32_1.htm EX-32.1 8413
6 EX-32.2 igms-ex32_2.htm EX-32.2 8383
  Complete submission text file 0000950170-24-096639.txt   8355337

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT igms-20240630.xsd EX-101.SCH 1216157
68 EXTRACTED XBRL INSTANCE DOCUMENT igms-20240630_htm.xml XML 1286074
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39045 | Film No.: 241204047
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)